Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Biotech Stocks: Opportunities abound for Osiris Therapeutics (OSIR:NASDAQ)

‘This Maryland-based biotechnology firm develops treatments for conditions as varied as Crohn’s disease, knee arthritis, tissue damage, life-threatening Graft-versus-host disease and acute radiation syndrome.’ – Laura Cadden Osiris Therapeutics, Inc. creates therapeutic drugs from human mesenchymal stem cells (MSCs) retrieved from bone marrow donated by healthy adult volunteers. Bone regeneration = big bucks Earlier this month, Osiris announced the sale of its Osteocel unit to NuVasive for $85 million. Osteocel promotes bone regeneration and is used in spinal fusion and other orthopedic procedures. This deal provides Osiris with the money and ability to focus on the next generation of revolutionary products… products like Chondrogen, which works… SHARETHIS.addEntry({ title: "Biotech Stocks: Opportunities abound for Osiris Therapeutics (OSIR:NASDAQ)", url: "http://jutiagroup.com/2008/05/27/biotech-stocks-opportunities-abound-for-osiris-therapeutics-osirnasdaq/" });
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.